SPS
DAWN

Susquehanna Portfolio Strategies’s Day One Biopharmaceuticals DAWN Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Hold
57,379
– – 0.02% 596
2025
Q4 		$535K Sell
57,379
-35,176
-38% -$294K 0.01% 769
2025
Q3 		$653K Buy
+92,555
New +$637K 0.01% 763

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Susquehanna Portfolio Strategies's DAWN Position: Q1 2026 in Review

Susquehanna Portfolio Strategies held its Day One Biopharmaceuticals (DAWN) position steady in Q1 2026 at 57,379 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #596.

Susquehanna Portfolio Strategies first reported a position in DAWN in Q3 2025 and has held it in 3 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Susquehanna Portfolio Strategies held 57,379 shares of Day One Biopharmaceuticals worth $1.23M as of Q1 2026.
  • Susquehanna Portfolio Strategies left its Day One Biopharmaceuticals share count unchanged in Q1 2026.
  • Day One Biopharmaceuticals made up 0.02% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #596 holding.
  • Susquehanna Portfolio Strategies first reported a position in Day One Biopharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.